483 Grifols Therapeutics Mar 2001

483 Grifols Therapeutics Mar 2001

Jacqueline Diaz Albert FDA, Robert Jennings FDA, Sid Priesmeyer FDA, Barbara Frazier FDA$595.00 - Available Now

FDA investigators audited the Grifols Therapeutics - Clayton, NC, United States facility and issued inspectional observations (via FDA 483) on 21 Mar 2001.

Product details

  • Category: Biologics
  • Inspection end: 21 Mar 2001
  • Location: Clayton, United States
  • FEI: 1050373
Add To Cart